Eligibility for extended antithrombotic therapy for secondary prevention of acute coronary syndrome
نویسندگان
چکیده
منابع مشابه
Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
Patients with acute coronary syndrome (ACS) represent a major clinical burden, because they tend to experience recurrent ischemic events. Acute management of patients with ACS includes combination antithrombotic therapy composed of a parenteral anticoagulant and dual-antiplatelet therapy. Dual-antiplatelet therapy is also recommended for long-term secondary prevention of ACS. Despite advances i...
متن کامل[Antithrombotic therapy in acute coronary syndrome].
ABBREVIATIONS IN THIS CHAPTER ACS Acute coronary syndrome BMS Bare metal stent CABG Coronary artery bypass grafting DAPT Dual antiplatelet therapy DES Drug-eluting stent GPI Glycoprotein IIb/IIIa inhibitor HIT Heparin-induced thrombocytopenia NSTE ACS Non–ST-segment elevation acute coronary syndrome PCI Percutaneous coronary intervention STEMI ST-segment elevation myocardial infarction UA Unsta...
متن کاملLow-dose anticoagulation for secondary prevention in acute coronary syndrome.
After acute coronary syndrome (ACS), long-term dual antiplatelet therapy with acetylsalicylic acid and a P2Y(12) platelet receptor antagonist is the standard of care for secondary prevention. Despite the introduction of more potent P2Y(12) receptor antagonists, the risk of a recurrent vascular event within 12 months remains at approximately 10%, indicating a need for improved secondary preventi...
متن کاملRecent advances in antithrombotic therapy after acute coronary syndrome.
egory of coronary heart disease that ranges from unstable angina to ST elevation myocardial infarction (MI). Its initial evaluation relies heavily on rapid triage according to the electrocardiogram and cardiac biomarkers. The cornerstone of treatment for ST ele vation MI is rapid reperfusion, which can be achieved either by fibrinolysis or primary percutaneous coronary intervention (PCI). When ...
متن کاملEvidenced-Based Antithrombotic Therapy for Acute Coronary Syndromes
Patients with diabetes mellitus (DM) and acute coronary syndromes (ACSs) are at particularly high risk for recurrent cardiovascular events, including death. The reason for this increased risk is multifactorial, including underutilization of evidencebased medications in these patients (1). More research is needed to identify both the optimal antithrombotic strategy and duration of therapy, and g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista Portuguesa de Cardiologia
سال: 2020
ISSN: 0870-2551
DOI: 10.1016/j.repc.2020.02.012